APO Research
Talk to an analyst

APO RESEARCH · REPORT

Male Infertility Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Male Infertility Treatment Market Analysis and Forecast 2026-2032

19 December 2025208 pages

Choose your research edition.

Industry ResearchMale Infertility Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Male Infertility Treatment Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Male Infertility Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Male Infertility Treatment Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Male Infertility Treatment Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Male Infertility Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Male Infertility Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Male Infertility Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Male Infertility Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Male Infertility Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Male Infertility Treatment include Zhejiang Xianju Pharmaceutical Co.,Ltd., Church & Dwight, Livzon Pharmaceutical Group Inc., Eli Lilly and Company, GeneScience Pharmaceuticals Co., Ltd., Bayer, Bristol Myers Squibb, SCSA diagnostics and Merck Serono, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Male Infertility Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Male Infertility Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Male Infertility Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Male Infertility Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Male Infertility Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Male Infertility Treatment revenue, projected growth trends, production technology, application and end-user industry.

Male Infertility Treatment Segment by Company

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Church & Dwight

Livzon Pharmaceutical Group Inc.

Eli Lilly and Company

GeneScience Pharmaceuticals Co., Ltd.

Bayer

Bristol Myers Squibb

SCSA diagnostics

Merck Serono

Intas Pharma

Intas Biopharmaceuticals

Halotech DNA

Cadila

Aytu BioScience

ASKA Pharmaceutical Co., Ltd.

Andrology Solutions

Abeona Therapeutics Inc.

Male Infertility Treatment Segment by Type

Oxidative Stress Analysis

Microscopic Examination

Sperm Agglutination

Sperm Penetration Assay

DNA Fragmentation Technique

Computer Assisted Semen Analysis

Male Infertility Treatment Segment by Application

Hospitals

Clinics

Others

Male Infertility Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Male Infertility Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Male Infertility Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Male Infertility Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Male Infertility Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Male Infertility Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Male Infertility Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Male Infertility Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oxidative Stress Analysis Major Player Table 3. Microscopic Examination Major Player Table 4. Sperm Agglutination Major Player Table 5. Sperm Penetration Assay Major Player Table 6. DNA Fragmentation Technique Major Player Table 7. Computer Assisted Semen Analysis Major Player Table 8. Global Male Infertility Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospitals Major Player Table 10. Clinics Major Player Table 11. Others Major Player Table 12. Male Infertility Treatment Industry Trends Table 13. Male Infertility Treatment Industry Drivers Table 14. Male Infertility Treatment Industry Opportunities and Challenges Table 15. Male Infertility Treatment Industry Restraints Table 16. Global Male Infertility Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Male Infertility Treatment Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Male Infertility Treatment Market Share by Region (2021-2026) Table 19. Global Male Infertility Treatment Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Male Infertility Treatment Market Share by Region (2027-2032) Table 21. Global Male Infertility Treatment Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Male Infertility Treatment Revenue Market Share by Players (2021-2026) Table 23. Global Male Infertility Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Male Infertility Treatment Key Players Headquarters & Area Served Table 25. Global Male Infertility Treatment Players, Product Type & Application Table 26. Global Male Infertility Treatment Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Male Infertility Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Male Infertility Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Male Infertility Treatment Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Male Infertility Treatment Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Male Infertility Treatment Revenue Market Share by Type (2021-2026) Table 33. Global Male Infertility Treatment Revenue Market Share by Type (2027-2032) Table 34. Global Male Infertility Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Male Infertility Treatment Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Male Infertility Treatment Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Male Infertility Treatment Revenue Market Share by Application (2021-2026) Table 38. Global Male Infertility Treatment Revenue Market Share by Application (2027-2032) Table 39. Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Information Table 40. Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview Table 41. Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product Portfolio Table 43. Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Development Table 44. Church & Dwight Company Information Table 45. Church & Dwight Business Overview Table 46. Church & Dwight Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Church & Dwight Male Infertility Treatment Product Portfolio Table 48. Church & Dwight Recent Development Table 49. Livzon Pharmaceutical Group Inc. Company Information Table 50. Livzon Pharmaceutical Group Inc. Business Overview Table 51. Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product Portfolio Table 53. Livzon Pharmaceutical Group Inc. Recent Development Table 54. Eli Lilly and Company Company Information Table 55. Eli Lilly and Company Business Overview Table 56. Eli Lilly and Company Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Eli Lilly and Company Male Infertility Treatment Product Portfolio Table 58. Eli Lilly and Company Recent Development Table 59. GeneScience Pharmaceuticals Co., Ltd. Company Information Table 60. GeneScience Pharmaceuticals Co., Ltd. Business Overview Table 61. GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product Portfolio Table 63. GeneScience Pharmaceuticals Co., Ltd. Recent Development Table 64. Bayer Company Information Table 65. Bayer Business Overview Table 66. Bayer Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Bayer Male Infertility Treatment Product Portfolio Table 68. Bayer Recent Development Table 69. Bristol Myers Squibb Company Information Table 70. Bristol Myers Squibb Business Overview Table 71. Bristol Myers Squibb Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Bristol Myers Squibb Male Infertility Treatment Product Portfolio Table 73. Bristol Myers Squibb Recent Development Table 74. SCSA diagnostics Company Information Table 75. SCSA diagnostics Business Overview Table 76. SCSA diagnostics Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. SCSA diagnostics Male Infertility Treatment Product Portfolio Table 78. SCSA diagnostics Recent Development Table 79. Merck Serono Company Information Table 80. Merck Serono Business Overview Table 81. Merck Serono Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Merck Serono Male Infertility Treatment Product Portfolio Table 83. Merck Serono Recent Development Table 84. Intas Pharma Company Information Table 85. Intas Pharma Business Overview Table 86. Intas Pharma Male Infertility Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Intas Pharma Male Infertility Treatment Product Portfolio Table 88. Intas Pharma Recent Development Table 89. Intas Biopharmaceuticals Company Information Table 90. Intas Biopharmaceuticals Business Overview Table 91. Intas Biopharmaceuticals Male Infertility Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Intas Biopharmaceuticals Male Infertility Treatment Product Portfolio Table 93. Intas Biopharmaceuticals Recent Development Table 94. Halotech DNA Company Information Table 95. Halotech DNA Business Overview Table 96. Halotech DNA Male Infertility Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Halotech DNA Male Infertility Treatment Product Portfolio Table 98. Halotech DNA Recent Development Table 99. Cadila Company Information Table 100. Cadila Business Overview Table 101. Cadila Male Infertility Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Cadila Male Infertility Treatment Product Portfolio Table 103. Cadila Recent Development Table 104. Aytu BioScience Company Information Table 105. Aytu BioScience Business Overview Table 106. Aytu BioScience Male Infertility Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Aytu BioScience Male Infertility Treatment Product Portfolio Table 108. Aytu BioScience Recent Development Table 109. ASKA Pharmaceutical Co., Ltd. Company Information Table 110. ASKA Pharmaceutical Co., Ltd. Business Overview Table 111. ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product Portfolio Table 113. ASKA Pharmaceutical Co., Ltd. Recent Development Table 114. Andrology Solutions Company Information Table 115. Andrology Solutions Business Overview Table 116. Andrology Solutions Male Infertility Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Andrology Solutions Male Infertility Treatment Product Portfolio Table 118. Andrology Solutions Recent Development Table 119. Abeona Therapeutics Inc. Company Information Table 120. Abeona Therapeutics Inc. Business Overview Table 121. Abeona Therapeutics Inc. Male Infertility Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Abeona Therapeutics Inc. Male Infertility Treatment Product Portfolio Table 123. Abeona Therapeutics Inc. Recent Development Table 124. North America Male Infertility Treatment Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Male Infertility Treatment Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Male Infertility Treatment Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Male Infertility Treatment Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Male Infertility Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Male Infertility Treatment Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Male Infertility Treatment Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Male Infertility Treatment Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Male Infertility Treatment Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Male Infertility Treatment Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Male Infertility Treatment Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Male Infertility Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Male Infertility Treatment Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Male Infertility Treatment Revenue by Country (US$ Million) & (2027-2032) Table 138. China Male Infertility Treatment Revenue by Type (2021-2026) & (US$ Million) Table 139. China Male Infertility Treatment Revenue by Type (2027-2032) & (US$ Million) Table 140. China Male Infertility Treatment Revenue by Application (2021-2026) & (US$ Million) Table 141. China Male Infertility Treatment Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Male Infertility Treatment Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Male Infertility Treatment Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Male Infertility Treatment Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Male Infertility Treatment Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Male Infertility Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Male Infertility Treatment Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Male Infertility Treatment Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Male Infertility Treatment Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Male Infertility Treatment Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Male Infertility Treatment Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Male Infertility Treatment Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Male Infertility Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Male Infertility Treatment Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Male Infertility Treatment Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Male Infertility Treatment Image Figure 2. Global Male Infertility Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Male Infertility Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oxidative Stress Analysis Image Figure 5. Microscopic Examination Image Figure 6. Sperm Agglutination Image Figure 7. Sperm Penetration Assay Image Figure 8. DNA Fragmentation Technique Image Figure 9. Computer Assisted Semen Analysis Image Figure 10. Global Male Infertility Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Male Infertility Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospitals Image Figure 13. Clinics Image Figure 14. Others Image Figure 15. Global Male Infertility Treatment Market Size (US$ Million) & (2021-2032) Figure 16. Global Male Infertility Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Male Infertility Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Male Infertility Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Male Infertility Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Male Infertility Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Male Infertility Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Male Infertility Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Male Infertility Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Male Infertility Treatment Revenue Market Share by Application (2021-2032) Figure 26. North America Male Infertility Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Male Infertility Treatment Revenue Share by Type (2021-2032) Figure 28. North America Male Infertility Treatment Revenue Share by Application (2021-2032) Figure 29. North America Male Infertility Treatment Revenue Share by Country (2021-2032) Figure 30. United States Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Male Infertility Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Male Infertility Treatment Revenue Share by Type (2021-2032) Figure 35. Europe Male Infertility Treatment Revenue Share by Application (2021-2032) Figure 36. Europe Male Infertility Treatment Revenue Share by Country (2021-2032) Figure 37. Germany Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Male Infertility Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Male Infertility Treatment Revenue Share by Type (2021-2032) Figure 47. China Male Infertility Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Male Infertility Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Male Infertility Treatment Revenue Share by Type (2021-2032) Figure 50. Asia Male Infertility Treatment Revenue Share by Application (2021-2032) Figure 51. Asia Male Infertility Treatment Revenue Share by Region (2021-2032) Figure 52. Japan Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Male Infertility Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Male Infertility Treatment Revenue Share by Type (2021-2032) Figure 60. SAMEA Male Infertility Treatment Revenue Share by Application (2021-2032) Figure 61. SAMEA Male Infertility Treatment Revenue Share by Country (2021-2032) Figure 62. Brazil Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Male Infertility Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Sperm Penetration Assay
  • DNA Fragmentation Technique
  • Computer Assisted Semen Analysis
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Zhejiang Xianju Pharmaceutical Co.,Ltd.
  • Church & Dwight
  • Livzon Pharmaceutical Group Inc.
  • Eli Lilly and Company
  • GeneScience Pharmaceuticals Co., Ltd.
  • Bayer
  • Bristol Myers Squibb
  • SCSA diagnostics
  • Merck Serono
  • Intas Pharma
  • Intas Biopharmaceuticals
  • Halotech DNA
  • Cadila
  • Aytu BioScience
  • ASKA Pharmaceutical Co., Ltd.
  • Andrology Solutions
  • Abeona Therapeutics Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Male Infertility Treatment Market by Type
  3. 1.2.1 Global Male Infertility Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oxidative Stress Analysis
  5. 1.2.3 Microscopic Examination
  6. 1.2.4 Sperm Agglutination
  7. 1.2.5 Sperm Penetration Assay
  8. 1.2.6 DNA Fragmentation Technique
  9. 1.2.7 Computer Assisted Semen Analysis
  10. 1.3 Male Infertility Treatment Market by Application
  11. 1.3.1 Global Male Infertility Treatment Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospitals
  13. 1.3.3 Clinics
  14. 1.3.4 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Male Infertility Treatment Market Dynamics
  1. 2.1 Male Infertility Treatment Industry Trends
  2. 2.2 Male Infertility Treatment Industry Drivers
  3. 2.3 Male Infertility Treatment Industry Opportunities and Challenges
  4. 2.4 Male Infertility Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Male Infertility Treatment Market Perspective (2021-2032)
  2. 3.2 Global Male Infertility Treatment Growth Trends by Region
  3. 3.2.1 Global Male Infertility Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Male Infertility Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Male Infertility Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Male Infertility Treatment Revenue by Players
  2. 4.1.1 Global Male Infertility Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Male Infertility Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Male Infertility Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Male Infertility Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Male Infertility Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Male Infertility Treatment Players, Product Type & Application
  8. 4.5 Global Male Infertility Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Male Infertility Treatment Market CR5 and HHI
  11. 4.6.3 2025 Male Infertility Treatment Tier 1, Tier 2, and Tier 3
5 Male Infertility Treatment Market Size by Type
  1. 5.1 Global Male Infertility Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Male Infertility Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Male Infertility Treatment Revenue Market Share by Type (2021-2032)
6 Male Infertility Treatment Market Size by Application
  1. 6.1 Global Male Infertility Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Male Infertility Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Male Infertility Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zhejiang Xianju Pharmaceutical Co.,Ltd.
  2. 7.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Information
  3. 7.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview
  4. 7.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product Portfolio
  6. 7.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments
  7. 7.2 Church & Dwight
  8. 7.2.1 Church & Dwight Company Information
  9. 7.2.2 Church & Dwight Business Overview
  10. 7.2.3 Church & Dwight Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Church & Dwight Male Infertility Treatment Product Portfolio
  12. 7.2.5 Church & Dwight Recent Developments
  13. 7.3 Livzon Pharmaceutical Group Inc.
  14. 7.3.1 Livzon Pharmaceutical Group Inc. Company Information
  15. 7.3.2 Livzon Pharmaceutical Group Inc. Business Overview
  16. 7.3.3 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product Portfolio
  18. 7.3.5 Livzon Pharmaceutical Group Inc. Recent Developments
  19. 7.4 Eli Lilly and Company
  20. 7.4.1 Eli Lilly and Company Company Information
  21. 7.4.2 Eli Lilly and Company Business Overview
  22. 7.4.3 Eli Lilly and Company Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly and Company Male Infertility Treatment Product Portfolio
  24. 7.4.5 Eli Lilly and Company Recent Developments
  25. 7.5 GeneScience Pharmaceuticals Co., Ltd.
  26. 7.5.1 GeneScience Pharmaceuticals Co., Ltd. Company Information
  27. 7.5.2 GeneScience Pharmaceuticals Co., Ltd. Business Overview
  28. 7.5.3 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product Portfolio
  30. 7.5.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Male Infertility Treatment Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 Bristol Myers Squibb
  38. 7.7.1 Bristol Myers Squibb Company Information
  39. 7.7.2 Bristol Myers Squibb Business Overview
  40. 7.7.3 Bristol Myers Squibb Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bristol Myers Squibb Male Infertility Treatment Product Portfolio
  42. 7.7.5 Bristol Myers Squibb Recent Developments
  43. 7.8 SCSA diagnostics
  44. 7.8.1 SCSA diagnostics Company Information
  45. 7.8.2 SCSA diagnostics Business Overview
  46. 7.8.3 SCSA diagnostics Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SCSA diagnostics Male Infertility Treatment Product Portfolio
  48. 7.8.5 SCSA diagnostics Recent Developments
  49. 7.9 Merck Serono
  50. 7.9.1 Merck Serono Company Information
  51. 7.9.2 Merck Serono Business Overview
  52. 7.9.3 Merck Serono Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Merck Serono Male Infertility Treatment Product Portfolio
  54. 7.9.5 Merck Serono Recent Developments
  55. 7.10 Intas Pharma
  56. 7.10.1 Intas Pharma Company Information
  57. 7.10.2 Intas Pharma Business Overview
  58. 7.10.3 Intas Pharma Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Intas Pharma Male Infertility Treatment Product Portfolio
  60. 7.10.5 Intas Pharma Recent Developments
  61. 7.11 Intas Biopharmaceuticals
  62. 7.11.1 Intas Biopharmaceuticals Company Information
  63. 7.11.2 Intas Biopharmaceuticals Business Overview
  64. 7.11.3 Intas Biopharmaceuticals Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Intas Biopharmaceuticals Male Infertility Treatment Product Portfolio
  66. 7.11.5 Intas Biopharmaceuticals Recent Developments
  67. 7.12 Halotech DNA
  68. 7.12.1 Halotech DNA Company Information
  69. 7.12.2 Halotech DNA Business Overview
  70. 7.12.3 Halotech DNA Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Halotech DNA Male Infertility Treatment Product Portfolio
  72. 7.12.5 Halotech DNA Recent Developments
  73. 7.13 Cadila
  74. 7.13.1 Cadila Company Information
  75. 7.13.2 Cadila Business Overview
  76. 7.13.3 Cadila Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cadila Male Infertility Treatment Product Portfolio
  78. 7.13.5 Cadila Recent Developments
  79. 7.14 Aytu BioScience
  80. 7.14.1 Aytu BioScience Company Information
  81. 7.14.2 Aytu BioScience Business Overview
  82. 7.14.3 Aytu BioScience Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Aytu BioScience Male Infertility Treatment Product Portfolio
  84. 7.14.5 Aytu BioScience Recent Developments
  85. 7.15 ASKA Pharmaceutical Co., Ltd.
  86. 7.15.1 ASKA Pharmaceutical Co., Ltd. Company Information
  87. 7.15.2 ASKA Pharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product Portfolio
  90. 7.15.5 ASKA Pharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Andrology Solutions
  92. 7.16.1 Andrology Solutions Company Information
  93. 7.16.2 Andrology Solutions Business Overview
  94. 7.16.3 Andrology Solutions Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Andrology Solutions Male Infertility Treatment Product Portfolio
  96. 7.16.5 Andrology Solutions Recent Developments
  97. 7.17 Abeona Therapeutics Inc.
  98. 7.17.1 Abeona Therapeutics Inc. Company Information
  99. 7.17.2 Abeona Therapeutics Inc. Business Overview
  100. 7.17.3 Abeona Therapeutics Inc. Male Infertility Treatment Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Abeona Therapeutics Inc. Male Infertility Treatment Product Portfolio
  102. 7.17.5 Abeona Therapeutics Inc. Recent Developments
8 North America
  1. 8.1 North America Male Infertility Treatment Revenue (2021-2032)
  2. 8.2 North America Male Infertility Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Male Infertility Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Male Infertility Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Male Infertility Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Male Infertility Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Male Infertility Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Male Infertility Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Male Infertility Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Male Infertility Treatment Revenue by Country
  11. 8.6.1 North America Male Infertility Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Male Infertility Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Male Infertility Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Male Infertility Treatment Revenue (2021-2032)
  2. 9.2 Europe Male Infertility Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Male Infertility Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Male Infertility Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Male Infertility Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Male Infertility Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Male Infertility Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Male Infertility Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Male Infertility Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Male Infertility Treatment Revenue by Country
  11. 9.6.1 Europe Male Infertility Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Male Infertility Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Male Infertility Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Male Infertility Treatment Revenue (2021-2032)
  2. 10.2 China Male Infertility Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Male Infertility Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Male Infertility Treatment Revenue by Type (2027-2032)
  5. 10.3 China Male Infertility Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Male Infertility Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Male Infertility Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Male Infertility Treatment Revenue by Application (2027-2032)
  9. 10.5 China Male Infertility Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Male Infertility Treatment Revenue (2021-2032)
  2. 11.2 Asia Male Infertility Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Male Infertility Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Male Infertility Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Male Infertility Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Male Infertility Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Male Infertility Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Male Infertility Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Male Infertility Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Male Infertility Treatment Revenue by Country
  11. 11.6.1 Asia Male Infertility Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Male Infertility Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Male Infertility Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Male Infertility Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Male Infertility Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Male Infertility Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Male Infertility Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Male Infertility Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Male Infertility Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Male Infertility Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Male Infertility Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Male Infertility Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Male Infertility Treatment Revenue by Country
  11. 12.6.1 SAMEA Male Infertility Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Male Infertility Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Male Infertility Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst